Arkolith/Insider Trading/JAZZ/Form 4

Carr Patricia

SVP, Chief Accounting OfficerJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed Mar 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$235K
Net Open-Market Flow
-$235K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 9, 2026Sell(S)1K$182.94$235K7K
Mar 5, 2026Tax withholding(F)1K$186.77$268K8K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001784606-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML